Results 11 to 20 of about 12,790 (151)

Efficacy and safety of D-penicillamine, trientine, and zinc in pediatric Wilson disease patients. [PDF]

Orphanet J Rare Dis
Lee EJ, Woo MH, Moon JS, Ko JS.
europepmc   +3 more sources

Comparative management practices of Wilson disease in Californian and Italian providers [PDF]

Journal of Health, Population and Nutrition
Background There is a scarcity of randomized and high-quality studies to aid clinicians in management and treatment of Wilson disease (WD). Even amongst society practice guidelines in North America and Europe, diagnosis and management of WD varies.
Sandy Vien, Colin McNamara, Ronald Hsu, Massimo Zuin, Valentina Medici   +4 more
doaj   +2 more sources

Retraction notice to "Novel fabrication of Cu(II)-incorporated chiral d-penicillamine-chitosan nanocomposites enantio-selectively inhibit the induced amyloid β aggregation for Alzheimer's disease therapy" [Heliyon 10 (2024) e23563]. [PDF]

Heliyon
Zhao F, Yang H, Gao Z, Liu H, Wu P, Li B, Yu H, Shao J.   +7 more
europepmc   +2 more sources

Construction and Application of an Electrochemical Sensor for Determination of D-Penicillamine Based on Modified Carbon Paste Electrode. [PDF]

Micromachines (Basel)
Mohammadnavaz A, Beitollahi H, Modiri S.
europepmc   +3 more sources

Benefits and drawbacks of current copper chelators in Wilson disease [PDF]

Romanian Journal of Neurology, 2023
Background. Wilson disease (WD) is an autosomal-recessive disorder of copper metabolism, caused by mutations in the ATP7B gene, which codes for a membrane-bound copper-binding ATPase.
Ioan-Cristian Lupescu, Maria Speranta Iacob, Razvan Iacob, Daniela Anghel, Octavia Adriana Dulamea, Crisanda Vilciu, Liliana Gheorghe   +6 more
doaj   +1 more source

D-penicillamine-induced Elastosis Perforans Serpiginosa [PDF]

Chinese Medical Journal, 2017
Xue-Yan Yao, Guang-Dong Wen, Cheng Zhou, Bo-Yang Liu, Juan Du, Zhou Chen, Jian-Zhong Zhang   +6 more
doaj   +2 more sources

Lead(II) binding to the chelating agent D-penicillamine in aqueous solution. [PDF]

Inorg Chem, 2014
Sisombath NS, Jalilehvand F, Schell AC, Wu Q.   +3 more
europepmc   +3 more sources

The Effects of Succimer and Penicillamine on Acute Lead Poisoning Patients

International Journal of Medical Toxicology and Forensic Medicine, 2021
Background: Lead poisoning was on the rise in recent years. There exists a lack of easy access to some of the main chelator drugs in developing countries.
Gholamali , Negar Molavi, Rokhsareh Meamar, Akbar Hasanzadeh, Nastaran Eizadi-Mood   +4 more
doaj   +1 more source

Inhibitory effect of D-penicillamine stabilized silver cluster on Escherichia coli and Staphylococcus aureus

Zhongguo gonggong weisheng, 2022
Objective To observe inhibitory effect of silver cluster assemblies capped by D-penicillamine on Escherichia coli (E.coli) and Staphylococcus aureus (S.aureus).
Yi HAN, Ling-can KONG, Geng-wei LI
doaj   +1 more source

The Biochemical Outcome of two Treatment Protocols in Patients With Opium-associated Lead Poisoning: A Cross-sectional Study in North of Iran

International Journal of Medical Toxicology and Forensic Medicine, 2021
Background: Lead is a potent toxin that targets heme synthesis and some antioxidant enzymes that induce oxidative stress. Lead exposure remains one of the significant health concerns all over the world.
Alireza Badsar, Zeynab Gholami, Morteza Rahbar Taramsari, Zahra Atrkar Roshan, Hamid Mohammadi Kojidi, MonirehAghajany-Nasab   +5 more
doaj   +1 more source